ENRIQUE
ALAVA CASADO
Forscher in der Zeit 2012-2013
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Bellvitge (4)
2015
-
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget, Vol. 6, Núm. 22, pp. 18875-18890
2012
-
Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin
Journal of Biological Chemistry, Vol. 287, Núm. 32, pp. 26495-26505
2011
-
Guía de práctica clínica en los sarcomas de partes blandas
Medicina Clinica
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 475, Núm. 7354, pp. 101-105